Edap Tms SA FOCL
Biotechnology: Electromedical & Electrotherapeutic Apparatus · data as of November 13, 2026
Edap Tms SA (FOCL) is a healthcare company listed in the US with a market value of about $153M. In fiscal year 2025 it had revenue of $71M and net income of -$29M, a net margin of -41.5%.
Its overall Stock Analiz score is 0.4 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 7% a year, a 5-year average ROIC of -42%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 67% below the current price.
About Edap Tms SA
Edap Tms SA is listed in the US and classified in biotechnology: electromedical & electrotherapeutic apparatus. Revenue went from $20M in 2013 to $71M in 2025, growth of about 10.9% a year. It was profitable in 1 of the last 10 years in our data. It spends 14% of revenue on research and development.
Score: 0.4 / 5
Checks passed
- 3-year revenue growth above 10% a year
- Strong R&D investment or growth above 20%
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71M | $69M | $59M | $50M | $51M | $50M | $45M | $43M | — | $24M |
| Net income | -$29M | -$21M | — | — | — | — | -$387M | -$817M | $4.1B | -$1.8B |
| Free cash flow | — | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | $-0.62 | $-0.44 | — | — | — | — | $-8.21 | $-17.30 | $85.77 | $-38.43 |
| Net margin | -41.5% | -29.7% | — | — | — | — | -864.0% | -1909.3% | — | -7608.2% |
| ROIC | -48.1% | -35.2% | — | — | — | — | — | — | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Edap Tms SA stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 67% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Edap Tms SA pay a dividend?
Not currently.
Is Edap Tms SA a good stock to buy?
We do not give buy or sell advice. Edap Tms SA scores 0.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.